The regulatory authority contacts the regulatory affairs professional regarding a complaint about a drug produced by the company. A consumer reported to the regulatory authority that the tablets have a slightly different color and break easily.
Which of the following actions should the regulatory affairs professional take?

• A.Respond to the regulatory authority that the company will provide copies of the relevant
  QC records for batch release.
• B.Respond to the regulatory authority that the product subject to the complaint is most likely a counterfeit product.
• C.Ask that the regulatory authority provide the actual product subject to the complaint.
• D.Ask that the regulatory authority provide the batch number printed on the packaging of the affected product.

Comment: *

Name: *

Email: *

Verification: *

During face-to-face meetings with the regulatory authority to address submission issues, what is the BEST choice for the number of company representatives who should attend?

• A.As many as government attendees
• B.As many as required by international standards
• C.All senior management from the main office
• D.The minimum number of attendees necessary to address the issues

Comment: *

Name: *

Email: *

Verification: *

Which of the following BEST describes the process of post-marketing surveillance for healthcare products?

• A.Vigilance procedure to notify the regulatory authorities about serious incidents
• B.Systematic procedure to review experiences with the products in use
• C.Vigilance procedure to ensure the full traceability of the products
• D.Systematic procedure to review published scientific journals

Comment: *

Name: *

Email: *

Verification: *

Which of the following claims would classify an apple as a drug?

• A."It will make you look younger."
• B."It will prevent colds."
• C."It will whiten teeth."
• D."It will satisfy hunger."

Comment: *

Name: *

Email: *

Verification: *

As a member of the product launch review committee, a regulatory affairs professional discovers a major issue with the labeling of a product prior to production. In addition to informing the committee, which is the BEST approach to address the issue?

• A.Inform the regulatory authorities.
• B.Abort the product launch.
• C.Correct the label text.
• D.Delay the start of product production.

Comment: *

Name: *

Email: *

Verification: *